Zithromax Injection, Powder, Lyophilized, For Solution
Product Images NDC 0069-0400

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zithromax (NDC 0069-0400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zithromax 01)

FDA Label Image

Logo (Zithromax 02)

FDA Label Image

Principal Display Panel (500 mg Vial Label)

FDA Label Image

Principal Display Panel (500 mg Vial Carton)

Principal Display Panel (500 mg Vial Carton)
Zithromax is a medication that comes in the form of single-dose vials that contain 500 mg/vial of azithromycin for injection. It is for intravenous use only and must be reconstituted as directed in the accompanying prescribing information. Each vial is equivalent to 500 mg of azithromycin and should not be used after 24 hours from reconstitution. The medication is produced in Ireland, by the Division of Pfizer Inc., NY. The rest of the text is illegible.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.